SME Times is powered by   
Search News
Just in:   • Crude oil prices surge over 3 pc over Iran tensions, Trump deadline  • Sensex, Nifty slide 1 pc as Hormuz deadline by US rattles markets  • Sensex, Nifty extend rally for 3rd day on hopes of US-Iran de-escalation  • Global energy flows disrupted by West Asia crisis: SEBI Chairman  • CAIT urges govt to implement credit relief, input cost stabilisation measures amid Iran war 
Last updated: 27 Feb, 2025  

js.jpg India emerging as global biotech innovation hub: Jitendra Singh

js.jpg
   Top Stories
» Sensex, Nifty slide 1 pc as Hormuz deadline by US rattles markets
» Sensex, Nifty extend rally for 3rd day on hopes of US-Iran de-escalation
» CAIT urges govt to implement credit relief, input cost stabilisation measures amid Iran war
» RBI MPC meet begins, status quo on policy rate likely amid West Asia tensions
» Govt launches programme to train scientists in Governance under Mission Karmayogi
IANS | 27 Feb, 2025

With 9,000 biotech startups, India has emerged as a global biotech innovation hub, said Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, on Wednesday.

He said this while undertaking a review of research facilities at CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh.

"The number of biotech startups in India has grown exponentially from just 50 in 2014 to nearly 9,000 today, solidifying India's position as a global hub for biotech innovation," Singh said.

He informed that India now ranks third in the Asia-Pacific region and 12th globally in bio-manufacturing, underscoring the increasing importance of research in microbial genetics, infectious diseases, fermentation technology, environmental microbiology, and bioinformatics.

At the Institute, he also inspected a microbe repository and took updates on ongoing projects.

"Microbial technology is a crucial pillar of biotechnology," the MoS said, while emphasising its growing significance in shaping the next generation industrial revolution.

Crediting Prime Minister Narendra Modi for the groundbreaking New BioE3 Policy, which places a renewed focus on biomanufacturing and bio foundries, Singh underscored India's rapid progress in the biotech sector.

“India’s bioeconomy has witnessed an extraordinary surge from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030,” he added.

Further, the Minister connected virtually with CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur, to inaugurate several new facilities and participate in critical scientific discussions.

He joined the EMBO Workshop on High Elevation Plant Adaptation in a Changing Climate (HEPACC) and the Industry, Farmer & Academia (IFA) Meet, inaugurated a New Tulip Garden at Palampur in Himachal Pradesh, and launched products developed by agri-startups that have been supported by the institute, fostering innovation in the agricultural sector.

"By integrating scientific research, industry collaboration, and government policies, the rich biodiversity of Himalayan states can be harnessed for economic prosperity," Singh said. He added that it will also benefit farmers and advance India’s scientific ecosystem.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹94.25
₹92.55
UK Pound
₹125.95
₹121.95
Euro
₹108.95
₹105.3
Japanese Yen ₹59.4 ₹57.6
As on 02 Apr, 2026
  Daily Poll
What is the biggest war impact on MSMEs?
 Export Disruption
 Raw Material Spike
 Freight Cost Surge
 Payment Delays
 Currency Volatility
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter